diagnostics

Even More Woes for Illumina’s Proposed Acquisition of Grail
Even More Woes for Illumina’s Proposed Acquisition of Grail
Medical Devices and Diagnostics Industry
Illumina
Grail
M&A
diagnostics
FTC
Flag link:
Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves
Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves
Forbes
Abbott Labs
COVID-19
earnings
diagnostics
Flag link:
A new market beckons for Alzheimer’s blood tests
A new market beckons for Alzheimer’s blood tests
EP Vantage
Alzheimer's disease
diagnostics
donanemab
Eli Lilly
Biogen
Quanterix
Flag link:
Diasorin heads to the US with $1.8bn Luminex deal
Diasorin heads to the US with $1.8bn Luminex deal
EP Vantage
Diasorin Molecular
Luminex
diagnostics
M&A
COVID-19
Flag link:
Could Illumina's Quest to Acquire GRAIL Fail?
Could Illumina's Quest to Acquire GRAIL Fail?
Motley Fool
Illumina
Grail
M&A
liquid biopsies
diagnostics
Flag link:
Symbiotica and Quidel Score FDA Authorizations for COVID-19 Tests
Symbiotica and Quidel Score FDA Authorizations for COVID-19 Tests
Xtalks
diagnostics
COVID-19
FDA
Emergency Use Authorization
SymbioticA
Quidel
Flag link:
Abbott, BD, Quidel tests get EUAs for asymptomatic COVID-19 serial screening
Abbott, BD, Quidel tests get EUAs for asymptomatic COVID-19 serial screening
Medtech Dive
diagnostics
FDA
Emergency Use Authorization
Abbott Labs
Becton Dickinson
Quidel
COVID-19
Flag link:
IQVIA pays Quest Diagnostics $760M to get full control of central lab joint venture
IQVIA pays Quest Diagnostics $760M to get full control of central lab joint venture
MedCity News
IQVIA
Quest Diagnostics
Q2 Solutions
diagnostics
Flag link:
FDA Grants Marketing Authorization to BioFire’s Multiplexed COVID Test – Lines Have Been Drawn
FDA Grants Marketing Authorization to BioFire’s Multiplexed COVID Test – Lines Have Been Drawn
FDA Law Blog
FDA
BioFire Diagnostics
COVID-19
diagnostics
De Novo
Flag link:
Abbott awarded $255M federal contract for rapid COVID-19 antigen tests
Abbott awarded $255M federal contract for rapid COVID-19 antigen tests
Medtech Dive
Abbott Labs
HHS
diagnostics
COVID-19
BinaxNOW
government contracts
Flag link:
Potential False Results with Roche Molecular Systems’ SARS-CoV-2 Assay
Potential False Results with Roche Molecular Systems’ SARS-CoV-2 Assay
FDA Law Blog
Roche Molecular Systems
COVID-19
diagnostics
Roche
Flag link:
FDA authorizes first COVID test via traditional review pathway
FDA authorizes first COVID test via traditional review pathway
RAPS.org
FDA
510(k)
diagnostics
COVID-19
BioFire Diagnostics
Flag link:
New French coronavirus variant appears to bypass standard tests
New French coronavirus variant appears to bypass standard tests
Politico
COVID-19
COVID-19 variants
France
diagnostics
Flag link:
Roche launches test to monitor emerging coronavirus variants
Roche launches test to monitor emerging coronavirus variants
Pharmaforum
Roche
diagnostics
COVID-19
COVID-19 variants
Flag link:
Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
Endpoints
Roche
Genentech
M&A
GenMark Diagnostics
diagnostics
Flag link:
Endemic COVID-19 Needs Novel, Prognostic Tests to Predict Severity and Progression
Endemic COVID-19 Needs Novel, Prognostic Tests to Predict Severity and Progression
BioSpace
COVID-19
pandemic
diagnostics
Flag link:
Abbott Goes on the ‘Offensive’ with Pandemic ‘Defense’ Coalition
Abbott Goes on the ‘Offensive’ with Pandemic ‘Defense’ Coalition
Medical Devices and Diagnostics Industry
Abbott Labs
devices
pandemic
diagnostics
Flag link:
COVID test developers get variant-related FDA guidance
COVID test developers get variant-related FDA guidance
RAPS.org
COVID-19
FDA
diagnostics
COVID-19 variants
Flag link:
Everlywell gets green light to sell at-home Covid-19 test kit without prescription
Everlywell gets green light to sell at-home Covid-19 test kit without prescription
MedCity News
FDA
diagnostics
COVID-19
OTC
Everlywell
Flag link:
Exact Sciences-Guardant rivalry in colorectal testing market heats up
Exact Sciences-Guardant rivalry in colorectal testing market heats up
Medtech Dive
EXACT Sciences
Guardant Health
diagnostics
colorectal cancer
Ashion Analytics
M&A
Flag link:

Pages